nach oben

Reactions Weekly

Erschienen in:

01.05.2022 | Case report

Imiquimod/quadrivalent-human-papillomavirus-vaccine

Worsening of acquired epidermodysplasia verruciformis and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Parietti M, et al. Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient. International Journal of STD and AIDS 33: 94-96, No. 1, 2022. Available from: URL: http://doi.org/10.1177/09564624211048343

Titel: Imiquimod/quadrivalent-human-papillomavirus-vaccine
Worsening of acquired epidermodysplasia verruciformis and lack of efficacy: case report
Publikationsdatum: 01.05.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-16011-7

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Atorvastatin/bempedoic acid interaction

Multiple drugs

Budesonide/formoterol

Antineoplastics

Multiple drugs

Multiple drugs